Trillium: 2Q Earnings Snapshot
MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Tuesday reported a loss of $4.9 million in its second quarter.
On a per-share basis, the Mississauga, Ontario-based company said it had a loss of 18 cents.
The developer of immune therapies that target cancer posted revenue of $25,400 in the period. Its adjusted revenue was $25,000.
The company’s shares closed at 31 cents. A year ago, they were trading at $5.50.